Rohan Shirur is a Florida State University biomathematics graduate preparing for a career in medicine with a focus on research and patient-centered care. He has earned a 3.9+ GPA and built a strong quantitative foundation through coursework and research in mathematical biology and computational modeling, including work on deterministic models of immune-pathogen interactions and treatment outcomes. Rohan Shirur is the first author of an undergraduate research paper currently under peer review, and he has gained clinical experience as a certified medical assistant across primary care, orthopedics, gastroenterology, and family medicine. He has also served as a surgical support technician at Tallahassee Memorial Hospital and contributed to research at Florida State University and the Georgia Tech Research Institute, including projects tied to NASA’s Kennedy Space Center. Outside academics, he volunteers in hospice care, cardiovascular health advocacy, and firefighting. His research background lends useful context to emerging treatment approaches such as phage therapy.
What Is Phage Therapy and How Does It Work?
As antibiotic resistance continues to pose a growing challenge to health care systems around the world, scientists and medical professionals are increasingly exploring alternative methods for treating bacterial infections. Among the most promising solutions is phage therapy, a treatment that uses bacteriophages, or phages, to target and destroy harmful bacteria.
Unlike viruses that infect humans, phages are highly specialized and infect only bacteria.
The phage then replicates within the bacterium until the cell bursts, releasing new phages that continue the process by attacking additional bacterial cells.
Antibiotic resistance has become a serious global health concern, as many bacterial strains have evolved defenses against medications that were once highly effective. Even bacteria that have developed resistance to multiple drugs may remain susceptible to specific bacteriophages, making phage therapy a potentially valuable option when conventional treatments have failed.
Benefits of Phage Therapy Over Traditional Antibiotics
Another significant benefit of phage therapy is its precision. Traditional antibiotics often eliminate a broad range of bacteria, including beneficial microorganisms that play essential roles in maintaining health.
The destruction of these helpful bacteria can disrupt the body’s microbiome and contribute to side effects such as digestive problems, weakened immune responses, and secondary infections.
Phages, by contrast, are far more selective. They target specific bacterial strains while leaving beneficial bacteria largely untouched, which may reduce the collateral harm associated with broad-spectrum antibiotic use.
Because bacteriophages specifically target bacteria and do not infect human cells, they are generally considered to have a favorable safety profile. Once the targeted bacteria are eliminated, the phages naturally decrease in number because they can no longer reproduce without their bacterial hosts.
This self-limiting characteristic distinguishes phage therapy from some treatments that remain active in the body long after their primary purpose has been achieved.
Bacteria constantly develop new ways to resist treatments, creating an ongoing challenge for health care providers. Phages, however, can also adapt over time.
As bacteria evolve defenses against specific phages, new phage variants may emerge that can overcome those defenses. This natural evolutionary relationship creates a dynamic system that may help maintain treatment effectiveness over extended periods.
Scientists can also isolate and identify new phages from the environment to address emerging bacterial threats, providing a degree of flexibility that is difficult to achieve with conventional antibiotics.
Applications of Phage Therapy in Medicine and Beyond
The potential applications of phage therapy extend beyond human medicine. Researchers are exploring its use in agriculture, veterinary medicine, and food safety.
In livestock production, phages may help reduce bacterial infections while decreasing reliance on antibiotics, which could help slow the development of antibiotic-resistant bacteria in agricultural settings and contribute to safer food production practices.
In the food industry, phages can be used to target harmful bacteria that contaminate food products, helping reduce the risk of foodborne illness and improving consumer safety.
Phage therapy also fits well within the growing field of personalized medicine. Because phages can be selected based on the specific bacteria causing an infection, treatments can be customized to meet the needs of individual patients.
In some cases, health care providers use combinations of multiple phages, known as phage cocktails, to broaden bacterial coverage and reduce the risk of resistance developing during treatment.
The Future of Phage Therapy
As interest in phage therapy continues to grow, researchers are conducting clinical trials and expanding scientific understanding of how phages can be integrated into modern health care practice.
The field’s ability to target antibiotic-resistant infections, preserve the integrity of the microbiome, adapt alongside evolving pathogens, and support individualized treatment makes phage therapy one of the most compelling innovations in contemporary infectious disease management.
About Rohan Shirur
Rohan Shirur is a biomathematics graduate of Florida State University based in Atlanta, Georgia, preparing for medical school with a focus on research and patient-centered care. He has clinical experience as a certified medical assistant in primary care, orthopedics, gastroenterology, and family medicine, as well as experience as a surgical support technician at Tallahassee Memorial Hospital. His research includes undergraduate work at Florida State University and the Georgia Tech Research Institute on mathematical models of biological systems. He is also active in hospice volunteering, cardiovascular health advocacy, and volunteer firefighting. See more